Cited by

• Sestrin 2 levels are associated with emphysematous phenotype of COPD.

  Angelakis L, Papaioannou AI, Papathanasiou E, Mazioti A, Kallieri M, Papatheodorou G, Patentalakis G, Hillas G, Papiris S, Koulouris N, Loukides S, Bakakos P. Angelakis L, et al. PLoS One. 2022 Aug 30;17(8):e0273652. doi: 10.1371/journal.pone.0273652. eCollection 2022. PLoS One. 2022. PMID: 36040980 Free PMC article.
• Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.

  Maniscalco M, Fuschillo S, Mormile I, Detoraki A, Sarnelli G, Paulis A, Spadaro G, Cantone E; PATH-2 TASK FORCE. Maniscalco M, et al. Cells. 2023 Oct 25;12(21):2518. doi: 10.3390/cells12212518. Cells. 2023. PMID: 37947596 Free PMC article. Review.
• Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.

  Palli SR, Frazer M, DuCharme M, Buikema AR, Anderson AJ, Franchino-Elder J. Palli SR, et al. J Manag Care Spec Pharm. 2020 Oct;26(10):1363-1374. doi: 10.18553/jmcp.2020.20159. Epub 2020 Jul 17. J Manag Care Spec Pharm. 2020. PMID: 32678719 Free PMC article.
• Th1/Th17 Cytokine Profiles are Associated with Disease Severity and Exacerbation Frequency in COPD Patients.

  Yu Y, Zhao L, Xie Y, Xu Y, Jiao W, Wu J, Deng X, Fang G, Xue Q, Zheng Y, Gao Z. Yu Y, et al. Int J Chron Obstruct Pulmon Dis. 2020 Jun 8;15:1287-1299. doi: 10.2147/COPD.S252097. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32606639 Free PMC article.
• Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease.

  Oishi K, Matsunaga K, Shirai T, Hirai K, Gon Y. Oishi K, et al. J Clin Med. 2020 Aug 18;9(8):2670. doi: 10.3390/jcm9082670. J Clin Med. 2020. PMID: 32824775 Free PMC article. Review.